Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-04-05 Sale |
2021-04-07 6:23 pm |
Revolution Medicines Inc. | RVMD | Svennilson Peter Director |
85,668 | $46.96 | $4,023,041 | 3,243,704 (Indirect Direct) |
View |
| 2021-02-17 Sale |
2021-02-19 5:32 pm |
CONSTELLATION PHARMACEUTICALS INC | CNST | COLUMN GROUP L P GOEDDEL DAVID V Svennilson Peter 10% Owner |
10,000 | $36.95 | $369,503 | 6,230,638 (Indirect Direct) |
View |
| 2020-11-16 Sale |
2020-11-18 6:58 pm |
Revolution Medicines Inc. | RVMD | Svennilson Peter Director 10% Owner |
2,027,156 | $36.4 | $73,788,478 | 3,806,436 (Indirect Direct) |
View |
| 2020-09-22 Sale |
2020-09-22 7:51 pm |
RAPT Therapeutics Inc. | RAPT | Svennilson Peter Director 10% Owner |
608,000 | $30.85 | $18,756,800 | 5,630,497 (Indirect) |
View |
| 2020-09-01 Purchase |
2020-09-03 5:32 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP Svennilson Peter GOEDDEL DAVID V Director 10% Owner |
64,089 | $17.65 | $1,131,358 | 18,242,932 (Indirect Direct) |
View |
| 2020-08-27 Purchase |
2020-08-31 5:02 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP GOEDDEL DAVID V Svennilson Peter Director 10% Owner |
62,494 | $17.83 | $1,114,382 | 18,178,843 (Indirect Direct) |
View |
| 2020-08-21 Purchase |
2020-08-25 6:50 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP GOEDDEL DAVID V Svennilson Peter Director 10% Owner |
18,445 | $17.96 | $331,349 | 18,116,349 (Indirect Direct) |
View |
| 2020-08-17 Sale |
2020-08-19 5:41 pm |
RAPT Therapeutics Inc. | RAPT | Svennilson Peter Director 10% Owner |
538,654 | $22.75 | $12,254,379 | 6,238,497 (Indirect) |
View |
| 2020-08-13 Purchase |
2020-08-17 7:12 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP GOEDDEL DAVID V Svennilson Peter Director 10% Owner |
64,313 | $17.65 | $1,135,362 | 18,097,904 (Indirect Direct) |
View |
| 2020-07-30 Purchase |
2020-08-03 5:57 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP GOEDDEL DAVID V Svennilson Peter Director 10% Owner |
732 | $17.99 | $13,169 | 18,033,591 (Indirect Direct) |
View |
| 2020-07-28 Purchase |
2020-07-30 8:08 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP GOEDDEL DAVID V Svennilson Peter Director 10% Owner |
4,105 | $17.99 | $73,849 | 18,032,859 (Indirect Direct) |
View |
| 2020-07-24 Purchase |
2020-07-28 5:40 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP GOEDDEL DAVID V Svennilson Peter Director 10% Owner |
72,583 | $17.93 | $1,301,643 | 18,028,754 (Indirect Direct) |
View |
| 2020-07-22 Purchase |
2020-07-23 5:44 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Ponoi Capital II LP Ponoi II Management LLC Svennilson Peter Kutzkey Tim GOEDDEL DAVID V Director 10% Owner |
193 | $18 | $3,474 | 17,976,977 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-03-31 Option Award |
2021-04-02 11:19 am |
N/A 2031-03-30 |
RAPT Therapeutics Inc. | RAPT | Svennilson Peter Director 10% Owner |
2,229 | $15.7 | 2,229 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-16 6:42 pm |
N/A N/A |
CONSTELLATION PHARMACEUTICALS INC | CNST | COLUMN GROUP L P GOEDDEL DAVID V Svennilson Peter 10% Owner |
30,107 | $1.55 | 6,240,638 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-16 6:42 pm |
N/A 2021-05-24 |
CONSTELLATION PHARMACEUTICALS INC | CNST | COLUMN GROUP L P GOEDDEL DAVID V Svennilson Peter 10% Owner |
30,107 | $0 | 6,240,638 (Direct) |
View |
| 2020-12-09 Other |
2020-12-11 6:39 pm |
N/A N/A |
Revolution Medicines Inc. | RVMD | Svennilson Peter Director |
1,106,850 | $0 | 2,497,220 (Indirect) |
View |
| 2020-07-28 Conversion |
2020-07-29 9:53 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | COLUMN GROUP L P Svennilson Peter 10% Owner |
6,672,548 | $0 | 686,274 (Direct) |
View |
Ownership |
2020-07-23 7:29 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | COLUMN GROUP L P Svennilson Peter 10% Owner |
0 | $0 | 6,774,214 (Direct) |
View |
| 2020-07-21 Exercise |
2020-07-23 5:44 pm |
2020-05-15 2020-08-18 |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Ponoi Capital II LP Ponoi II Management LLC Svennilson Peter Kutzkey Tim GOEDDEL DAVID V Director 10% Owner |
24,000 | $0 | 17,976,977 (Direct) |
View |
| 2020-07-21 Exercise |
2020-07-23 5:44 pm |
N/A N/A |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Ponoi Capital II LP Ponoi II Management LLC Svennilson Peter Kutzkey Tim GOEDDEL DAVID V Director 10% Owner |
24,000 | $13.35 | 17,976,977 (Direct) |
View |
| 2019-05-15 Option Award |
2020-07-23 5:44 pm |
2020-05-15 2029-05-14 |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Ponoi Capital II LP Ponoi II Management LLC Svennilson Peter Kutzkey Tim GOEDDEL DAVID V Director 10% Owner |
64,806 | $0 | 17,976,977 (Indirect) |
View |
| 2020-06-18 Option Award |
2020-06-19 5:35 pm |
N/A 2030-06-17 |
RAPT Therapeutics Inc. | RAPT | Svennilson Peter Director 10% Owner |
22,500 | $0 | 22,500 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 3:34 pm |
N/A 2030-06-16 |
Revolution Medicines Inc. | RVMD | Svennilson Peter Director 10% Owner |
32,552 | $0 | 8,009,936 (Direct) |
View |
| 2020-04-28 Conversion |
2020-04-28 5:10 pm |
N/A N/A |
Oric Pharmaceuticals Inc. | ORIC | Svennilson Peter Director 10% Owner |
4,693,181 | $0 | 4,768,181 (Indirect) |
View |